Melatonin Dose: Why 0.5 mg Often Beats 10 mg for Sleep

In controlled trials at MIT, a 0.3–0.5 mg dose of melatonin raised blood levels into the same range the brain produces naturally at night — and helped people fall asleep faster. Doses of 10 mg, now common in US gummies, can push levels roughly 40-fold above the natural peak, with no evidence of added sleep benefit and a higher chance of next-day fog. If you've tried melatonin and found it "didn't work" or left you groggy, the dose — not the hormone — may be the problem.

What melatonin actually does

Melatonin is not a sedative in the way prescription sleeping pills are. It's a hormone released by the pineal gland that tells the brain's master clock — the suprachiasmatic nucleus — that it's dark. Levels begin rising about two hours before habitual bedtime and peak in the middle of the night at roughly 60–200 pg/mL in young adults, a range that declines with age.

Because it's a timing signal rather than a knockout drug, dose works differently than most people assume. More melatonin doesn't create more sleep pressure; it simply floods receptors that evolved to respond to tiny concentrations. Oral doses of 3–10 mg produce blood levels many times the physiological peak, and those elevated levels persist longer into the night and the following morning.

What the dose-response studies show

The most cited work comes from MIT's clinical research center. In trials led by Richard Wurtman and Irina Zhdanova, 0.3 mg taken in the evening shortened sleep onset in adults aged 50 and over, while 3 mg added no measurable benefit and kept blood levels elevated into the next day. The researchers concluded that doses above roughly 1 mg exceed the useful range of the receptor system — a classic non-linear dose-response with a ceiling.

Broader evidence points the same way. A 2013 meta-analysis of 19 trials published in PLOS One found melatonin reduced sleep onset latency by about seven minutes on average and modestly improved self-rated sleep quality, across a wide range of doses with no clear advantage at the high end. A 2022 Cochrane review of melatonin for adult sleep disorders reached a similar verdict: small effects, low-certainty evidence, and no clear dose-response gradient.

Why 10 mg became the default

Regulation explains part of it. In the US and Canada, melatonin is sold as a dietary supplement, so doses are set by manufacturers rather than regulators — and marketing has drifted upward, with 5–10 mg gummies now standard on American shelves. In the UK, melatonin is prescription-only (the licensed product, Circadin, is 2 mg modified-release for adults 55+), and in Australia it has been available mainly as a 2 mg pharmacist-supplied product for people 55 and over. The countries that treat melatonin as a medicine sell the smallest doses.

There's also a measurement problem. A 2017 analysis in the Journal of Clinical Sleep Medicine tested 31 US supplements and found actual melatonin content ranged from 83% below to 478% above the label claim — chewable gummies were the most variable. A "10 mg" gummy could contain anywhere from under 2 mg to nearly 50 mg. Our take, clearly labeled as opinion: this single finding justifies choosing USP-verified products and starting at the lowest dose available.

Why this matters for your nights

The practical consequences of going low instead of high:

• Less grogginess. High doses are the main driver of the morning fogginess, vivid dreams and headaches people report with melatonin.
• Better timing. At 0.5 mg, blood levels follow a physiological curve, so a dose taken 1–2 hours before your target bedtime nudges the clock in the right direction.
• Fewer interaction risks. The NIH notes melatonin may interact with anticoagulants, anticonvulsants, immunosuppressants and diabetes medications — a reason not to overshoot at any age.
• Lower cost. Low-dose tablets cost less per effective night than mega-dose gummies.

How to try it: start with 0.5 mg (or split a 1 mg tablet), taken 30–60 minutes before bed if your goal is falling asleep, or 1–2 hours before your target bedtime if you're shifting your clock earlier. Give it two weeks at the same time each night. Keep evening lights dim — melatonin works with darkness, not against bright screens.

The honest counterpoint

The strongest scientific objection: the American Academy of Sleep Medicine's 2017 clinical practice guideline recommends against melatonin for chronic insomnia in adults, citing small trials and low-quality evidence. That is a legitimate reading of the data — for diagnosed insomnia disorder, the effect is modest and the trial base is weak.

The response: melatonin was never an insomnia drug. It's a chronobiotic — a timing signal. Its best-supported uses are delayed sleep-wake phase disorder, jet lag, shift work, and older adults whose natural melatonin output has declined. For chronic insomnia, the American College of Physicians recommends cognitive behavioral therapy for insomnia (CBT-I) as first-line treatment, not any pill. If you've needed melatonin nightly for more than three months, that's a reason to see a clinician — not to raise the dose.

Opinion, clearly labeled: the 10 mg habit is largely a marketing artifact that has made a mild, useful molecule look unreliable. Most people would do better with 0.5 mg, a consistent schedule, and bright light in the morning.

Bottom line

Melatonin at 0.3–0.5 mg reaches the range your body actually uses; 10 mg reaches a range your body never sees. Start low, time it to your clock, treat it as a signal rather than a sedative, and escalate only with medical advice.